key: cord-1031174-4t24wb52
authors: Mlouki, Imen; Zammit, Nawel; Ghammem, Rim; Ben Fredj, Sihem; Bannour, Rania; El Echi, Ansar; Ladhari, Hafsia; Haddedi, Adel; Ghodhbani, Mohamed Mizouni; Maatoug, Jihene; Ghannem, Hassen
title: Validity and reliability of a modified short version of a stigma scale for use among Tunisian COVID‐19 patients after quarantine: A cross‐sectional study
date: 2022-02-18
journal: Health Sci Rep
DOI: 10.1002/hsr2.520
sha: 0e00efdd418d9b7d6be3269397486fd3d3ea95e8
doc_id: 1031174
cord_uid: 4t24wb52

BACKGROUND AND AIM: The COVID‐19 is a stigmatizing infectious disease even after healing. Until now, no COVID‐19 stigma scale validated in Tunisian Arabic language among the general population is available. Developing such tools is necessary to detect COVID‐19 stigma and reduce it effectively. Indeed, stigmatization of COVID‐19 patients could increase the spread of this disease and its related mental health issues. We aimed at testing the validity of a translated and modified version of the 12‐item HIV stigma scale among Tunisian COVID‐19 patients. METHODS: A cross‐sectional study was conducted between November and December 2020 among a representative sample of COVID‐19 patients in the governorate of Sousse, Tunisia, after quarantine. The 12‐item HIV stigma scale was translated in Tunisian Arabic and then modified to be adapted to the Tunisian context. The preliminary modified version was administrated to the participants by pretrained medical doctors during phone calls. It consisted on 20 items covering the four stigma dimensions (personalized stigma, disclosure concerns, concerns with public attitudes, and negative self‐image). The psychometric evaluation of this version included internal consistency as well as principal component analysis (PCA). RESULTS: The responses of 346 COVID‐19 patients were obtained. Their median age was 40 years (interquartile range: 30‐54.5). Females represented 60.4% of them. The PCA resulted in a three factor solution with 14 items. This 14‐item scale demonstrated good internal consistency with a global Cronbach's α of 0.91 and values of 0.94, 0.93, and 0.98 for social stigma, negative self‐image, and disclosure concerns, respectively. CONCLUSION: This study provides a reliable and valid instrument for stigma measuring among Tunisian COVID‐19 patients. The use of this scale would contribute in reducing the spread of this new infectious disease and its related mental health issues.

The COVID-19 outbreak has provoked rejection of people with certain ethnic backgrounds, health care workers, patients with COVID- 19 infection as well as their families. 1 Indeed, a systematic review on previous infectious outbreaks over the last 20 years revealed a high prevalence of stigma related to this kind of disease. 2 This discriminatory behavior may remain even after recovery. 2 Consequently, COVID-19 patients may hide their infection episode and avoid medical care which can lead to severe consequences for their physical and mental health. 1 At the collective level, stigma may result in more difficulties in controlling the pandemic spread for public health authorities. [2] [3] [4] [5] A recent meta-analysis underlined higher prevalence of COVID-19 stigma in low and middle income countries including Arab countries. 6 However, a variety of tools was used to measure this issue in these countries. [6] [7] [8] Actually, little interest was given to develop and valid specific scales measuring COVID-19-related stigma among patients worldwide. 9, 10 Furthermore, several studies focused on stigma toward healthcare providers, while fewer studies assessed stigma among the general population. 9, 11 At the time of the current study, no Arabic scale was available to measure stigma in the Arab speaking countries. Besides, in the North African region, researchers put more emphasis on the clinical aspects of COVID-19 infection and overlooked its psychosocial impact. 12, 13 Providing valid tools to measure COVID-19 stigma is crucial not only for healthcare professionals but also for policy makers to monitor and reduce the spread of COVID-19 and its related mental health issues. 2 To address this gap, we translated, adapted, and tested the psychometric properties of the Berger-HIV stigma scale. 14 This tool would be able to measure COVID-19 related stigma among the Tunisian general population after quarantine accurately and reliably?

The HIV shares similar characteristics with COVID-19 in terms of social isolation, fear of contagion and community discrimination. 10 It also evaluate stigma in its various aspects: personalized stigma; disclosure concerns; negative self-image; and concern with public attitudes. 15 This questionnaire was widely used as screening tool for stigma in previous infectious outbreaks as well as in this current pandemic. 9, 10, 16, 17 Accordingly, we hypotheses that this tool would represent a reliable and accurate tool to measure COVID-19 related stigma among the Tunisian general population after quarantine.

Accordingly, the aim of the current study was to determine whether a translated and modified version of the 12-item HIV stigma scale is reliable and accurate among adults with COVID-19 infection after quarantine in Sousse, Tunisia.

A cross-sectional study was conducted between the sixth of November and the 12th of December 2020 among patients with confirmed SARS-COV-2 infection in the governorate of Sousse (Tunisia) during the third week after diagnosis.

Participants were recruited from a dynamic cohort of 375 patients newly diagnosed with COVID-19 in the governorate of Sousse. This cohort was followed to evaluate compliance with home-quarantine and the prognosis of COVID-19 among them. To constitute this cohort, simple random sampling of 15 patients was daily performed among the new declared COVID-19 cases between the 28th of October and the 28th of November 2020. The daily lists of patients newly diagnosed with COVID-19 were obtained from the Regional Health Direction of Sousse. These lists contained data about the sociodemographic characteristics, the origin, and contact information. Duplicated patients, those from other governorates and those without contact details were deleted from the lists before performing randomization. The mean of daily number of cases in the region was 67 ± 4 during the study period.

From this cohort of 375 patients, those above the age of 18 years and which gave informed consent were included to the current study. Foreign patients, those who were hospitalized and those with sensorial problems or any clinical condition that could affect comprehension capacities, were not included to the current study.

Three pretrained medical doctors administrated a pretested questionnaire written in Tunisian Arabic to each participant by interview during two phone calls. The first part of the questionnaire, administrated during the first week from diagnosis, served to collect data about the sociodemographic characteristics (age, gender, and profession), the setting of quarantine, the occurrence of new cases of COVID-19 at home or at work, and the impact of the COVID-19 on its professional and financial situation. The second part of the questionnaire, administrated during the fourth week from the diagnosis, focused on stigma related to the COVID-19 episode. Responses of participants were registered electronically using Google forms. To ovoid missing data, all responses were mandatory before sending each completed form.

The 40-item HIV stigma scale 14 . 15 This questionnaire was widely used as screening tool for stigma in previous infectious outbreaks as well as in this current pandemic. 9, 10, 16, 17 Thus, we used this short version with its four subscales intended to evaluate concerns with public attitudes, personalized stigma, negative selfimage, and disclosure concerns. 15 The response format was maintained: a 4-point Likert scale ranging from strongly disagree (1) to strongly agree (4).

Responses were then summed to calculate subscale scores. Higher scores indicate a greater level of Covid-19-related stigma. 

The experimental version of the stigma scale was pretested on a convenience sample of 30 patients 1 week after the end of their home quarantine to assess the cultural acceptability and the understandability of the items. Unclear items and those that were difficult to understand by two or more patients were reformulated taking into account their comments and the opinion of experts.

The experimental version of the stigma scale was given to two other experts who were familiar with psychometric methods for assessment of content validity. They evaluated the items with respect to appropriate wording, grammar, clarity, understandability, and relatedness to Tunisian culture. They were also required to review the items with respect to their relevance.

Confirmatory factor analysis was performed to extract main factors. Independent factors were obtained using principal component analysis (PCA). A factor was considered to be relevant only if its eigenvalue was greater than 1, to indicate that a component explains more variance than any single item. 21 Varimax orthogonal rotation with calculation of the Keizer-Meyer-Olkin index (KMO index) was then used to reorganize the representation of items for each selected factor. 22 The Bartlett's test of sphericity served to determine whether there was at least one significant correlation between two of the studied items. 23 Incomplete observations were deleted.

The reliability of the questionnaire was assessed, using internal consistency. Cronbach's alpha coefficients, showing how much each of the items in the questionnaire is related to the overall result, indicates acceptable reliability if it is above 0.7. 23

Data capture and analysis were performed using IBM Statistical Package for the Social Sciences version 10.

Descriptive statistics were reported as frequencies for categorical variables and as means and SDs for quantitative ones. All statistical tests were two-tailed, and P values <.05 were considered statistically significant.

This study was undertaken with respect of the rights and the integrity of people. The study protocol was approved by the Ethical Committee of Farhat Hached University Hospital. Permission from The Regional Health Direction was obtained. Verbal informed consents were obtained beforehand from all participants after providing explanations by the investigators about the aim of the study and confidentiality of the collected data. Participation was voluntary and the participants did not receive any payment. Data were anonymized for this study.

A total of 365 adults fulfilled the inclusion criteria. Of these patients, 14 were lost to follow-up and five did not gave consent to participate to the current study. 

Descriptive statistics for the scale are presented in Table 1 . Missing data were mainly in "concerns about public attitudes" and "personalized stigma" dimensions.

Highest scores were recorded on the questions "I did not tell anyone that I have COVID-19 except my close entourage" (2.32 ± 0.82) and "Telling someone I have COVID-19 is risky" (2.29 ± 0.81). We found mean scores of 15.9/32 (±4), 10.7/24 (±2.2), 6.9/12 ± 2.38, and 5.7/12 (±1.4) for concern about public attitudes, negative self-image, disclosure concerns, and personalized stigma, respectively (Table 1) 

Based on the participants' comments and considering the experts' opinion, items P1, P3, and D3 were modified. Accordingly, "touching me," "lost friends," and "very careful who I tell" were changed into "dealing with me despite my respect of social distancing and wearing mask," "friends stopped talking to me," and "I did not tell anyone except my close entourage," respectively. Figure 1 . This is another evidence for a three factor model of the scale.

The first factor involved as a combination of the original dimension "concerns about public attitudes" (C1, C2, and C3), the first item of the original dimension "personalized stigma" (P1) and three new items (C4, C5, and C8). This factor was renamed as "Social stigma."

The second factor resulted from two items from the original "negative self-image" dimension (N2 and N3) and two other new items (N4 and N6). This factor was not renamed. The third factor matched the entire original "disclosure concerns" dimension (D1, D2, and D3).

Four items loaded equally on factor one and two (P2, P3, C6, and C7). Two others (N1 and N5) saturated on components one and three (Table 3) . These six items were therefore removed: Two items from the original dimension "personalised stigma" (P2 and P3), one from the original dimension "negative self-image" (N1) and three from the eight added items (two were added to the "concerns about public attitudes" dimension [C6 and C7] and one was added to the "negative self-image" dimension [N5]). Table 3 , final factor analysis of the remaining 14 items revealed better construct validity than the 20-item scale.

The three factors explained 76% of the total variance. Internal consistency was also high for total score (0.91) and three subscales ( Table 3 ). The 14-item Arabic version is illustrated in the additional file (Appendix 1).

Regarding the lack of Tunisian Arabic tool to measure COVID- 

A guide to preventing and addressing social stigma associated with COVID-19

Anticipating COVID-19-related stigma in survivors and health-care workers: lessons from previous infectious diseases outbreaks-an integrative literature review. Psychiatry

Stigma and discrimination during COVID-19 pandemic

The psychological burden of COVID-19 stigma: evaluation of the mental health of isolated mild condition COVID-19 patients

Why communities should be the focus to reduce stigma attached to COVID-19

A systematic review and metaanalysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action

Stigma toward people with COVID-19 among the Lebanese population: a cross-sectional study of correlates and mediating effects

Fear of COVID-19 and stigmatization towards infected people among Jordanian people

COVID-19-related stigmatization among a sample of Egyptian healthcare workers

COVID-19-related stigma among inpatients with COVID-19 infection: a cross-sectional study from India

Development and initial validation of stigma towards healthcare providers working with COVID-19 patients scale (S19-HCPs)

A SIR-Poisson model for COVID-19: evolution and transmission inference in the Maghreb central regions

Evaluation of a COVID-19 IgM and IgG rapid test and assessment of specific antibody response in COVID-19 patients

Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale

Development of a 12-item short version of the HIV stigma scale. Health Qual Life Outcomes

Scarlett letter: a study based on experience of stigma by COVID-19 patients in quarantine

Stigma in coronavirus disease-19 survivors in Kashmir, India: a cross-sectional exploratory study

Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines

A questionnaire to assess social stigma

Mental health of nurses working at a government-designated hospital during a MERS-CoV outbreak: a cross-sectional study

An Easy Guide to Factor Analysis. London: Routledge

Evaluation de l'utilisation et de la présentation des résultats d'analyses factorielles et d'analyses en composantes principales en éducation

Characteristics and prognostic factors of COVID-19 among infected cases: a nationwide Tunisian analysis

COVID-19-related stigma and its association with mental health of health-care workers after quarantine in Vietnam

Late complications of COVID-19; a systematic review of current evidence

Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

We would like to thank all the team members of the Regional Direction of Health in the region of Sousse. All authors declare that the current work submitted to Health Science Reports has been done in accordance to these guidelines and that is has been performed in an ethical and responsible way, with no research misconduct, which includes, but is not limited to data fabrication and falsification, plagiarism, image manipulation, unethical research, biased reporting, authorship abuse, redundant or duplicate publication, and undeclared conflicts of interest.

No funding was received for conducting this study.

The authors report no actual or potential conflicts of interest. All Imen Mlouki had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.

Imen Mlouki affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; and that no important aspects of the study have been omitted.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

https://orcid.org/0000-0002-0706-239XNawel Zammit https://orcid.org/0000-0003-4410-295X